The Pro-inflammatory Cytokine, Interleukin-6, Enhances the Polarization of Alternatively Activated Macrophages

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2014 Apr 17

PMID 24736635

Citations 150

Authors

Maria Ruweka Fernando

Jose Luis Reyes

Jordan Iannuzzi

Gabriella Leung

Derek Mark McKay

Affiliations

Soon will be listed here.

Abstract

Macrophages are important innate immune cells that are associated with two distinct phenotypes: a pro-inflammatory (or classically activated) subset with prototypic macrophage functions such as inflammatory cytokine production and bactericidal activity, and an anti-inflammatory (or alternatively activated (AAM)) subset linked with wound healing and tissue repair processes. In this study, we examined the effect of interlukein-6 on human and murine macrophage polarization. The results indicate that despite being commonly associated with pro-inflammatory functions and being implicated in the pathogenesis/pathophysiology of numerous inflammatory diseases, interleukin-6 can enhance the polarization of AAMs, based on increased expression of hallmark markers: arginase-1, Ym1 and CD206; this effect required the AAM differentiating cytokines, IL-4 and IL-13. Co-treatment of AAMs with IL-6 resulted in spontaneous release of IL-10, suppressed LPS-induced nitric oxide production and inhibited cytokine production by activated CD4+ T cells - immunoregulatory features not observed in the 'parent' IL-4+IL-13-induced AAM. The effect of IL-6 required signal transducer and activator of transcription (STAT)-3, was partially dependent on up-regulation of the IL4Rα chain, and was independent of autocrine IL-10. In the presence of IFNγ, IL-6 promoted the production of IL-1β and TNFα suggesting that this cytokine can enhance the phenotype to which a macrophage has committed. This finding may explain the pleiotrophic nature of IL-6, where it is associated with the perpetuation and enhancement of disease in inflammatory situations, but is also necessary for resolution of inflammation and adequate wound healing to occur in others. Thus, the potential benefit of IL-6 in promoting an AAM, with its' anti-inflammatory and wound healing ability, may need to be considered in immunotherapies aimed at in vivo modulation or inhibition of IL-6.

Citing Articles

Biomimetic mineralized DCPA/ anti-CD47 containing thermo-sensitive injectable hydrogel for bone-metastatic prostate cancer treatment.

Tan S, Wang Q, Feng C, Pu X, Li D, Jiang F Mater Today Bio. 2025; 31:101573.

PMID: 40051525 PMC: 11883399. DOI: 10.1016/j.mtbio.2025.101573.

NLRP3: a key regulator of skin wound healing and macrophage-fibroblast interactions in mice.

Zhao J, Zhang S, Gong Z, Mao W, Bao W, Li Q Cell Commun Signal. 2025; 23(1):55.

PMID: 39881348 PMC: 11780867. DOI: 10.1186/s12964-025-02063-9.

Integrated transcriptomic analysis reveals dysregulated immune infiltration and pro-inflammatory cytokines in the secretory endometrium of recurrent implantation failure patients.

Zhou P, Mo D, Huang H, Xu J, Liao B, Wang Y Life Med. 2025; 3(5):lnae036.

PMID: 39872439 PMC: 11749484. DOI: 10.1093/lifemedi/lnae036.

Serotonin receptor 5-HT7 modulates inflammatory-associated functions of macrophages.

Bahr F, Muller F, Kasten M, Benen N, Sieve I, Scherr M Cell Mol Life Sci. 2025; 82(1):51.

PMID: 39833622 PMC: 11747067. DOI: 10.1007/s00018-024-05570-z.

Development of immunocompetent full thickness skin tissue constructs to model skin fibrosis for high-throughput drug screening.

Lim Y, Quinn R, Bharti K, Ferrer M, Zarkoob H, Song M Biofabrication. 2024; 17(1).

PMID: 39622178 PMC: 11638742. DOI: 10.1088/1758-5090/ad998c.

References

Qualls J, Neale G, Smith A, Koo M, DeFreitas A, Zhang H . Arginine usage in mycobacteria-infected macrophages depends on autocrine-paracrine cytokine signaling. Sci Signal. 2010; 3(135):ra62. PMC: 2928148. DOI: 10.1126/scisignal.2000955. View

Taams L, van Amelsfort J, Tiemessen M, Jacobs K, de Jong E, Akbar A . Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells. Hum Immunol. 2005; 66(3):222-30. PMC: 3904343. DOI: 10.1016/j.humimm.2004.12.006. View

Chomarat P, Banchereau J, Davoust J, Palucka A . IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immunol. 2001; 1(6):510-4. DOI: 10.1038/82763. View

Horsnell W, Brombacher F . Genes associated with alternatively activated macrophages discretely regulate helminth infection and pathogenesis in experimental mouse models. Immunobiology. 2010; 215(9-10):704-8. DOI: 10.1016/j.imbio.2010.05.011. View

Kurowska-Stolarska M, Stolarski B, Kewin P, Murphy G, Corrigan C, Ying S . IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol. 2009; 183(10):6469-77. DOI: 10.4049/jimmunol.0901575. View

McFarland-Mancini M, Funk H, Paluch A, Zhou M, Giridhar P, Mercer C . Differences in wound healing in mice with deficiency of IL-6 versus IL-6 receptor. J Immunol. 2010; 184(12):7219-28. DOI: 10.4049/jimmunol.0901929. View

Smolen J, Maini R . Interleukin-6: a new therapeutic target. Arthritis Res Ther. 2006; 8 Suppl 2:S5. PMC: 3226077. DOI: 10.1186/ar1969. View

Pesce J, Kaviratne M, Ramalingam T, Thompson R, Urban Jr J, Cheever A . The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J Clin Invest. 2006; 116(7):2044-55. PMC: 1479424. DOI: 10.1172/JCI27727. View

Steinman L . A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med. 2007; 13(2):139-45. DOI: 10.1038/nm1551. View

10.

Antignano F, Hamilton M, Patterson S, Ho V, Cohen C, Levings M . SHIP-deficient dendritic cells, unlike wild type dendritic cells, suppress T cell proliferation via a nitric oxide-independent mechanism. PLoS One. 2011; 6(7):e21893. PMC: 3130768. DOI: 10.1371/journal.pone.0021893. View

11.

Gordon S, Martinez F . Alternative activation of macrophages: mechanism and functions. Immunity. 2010; 32(5):593-604. DOI: 10.1016/j.immuni.2010.05.007. View

12.

Mircic M, Kavanaugh A . The clinical efficacy of tocilizumab in rheumatoid arthritis. Drugs Today (Barc). 2009; 45(3):189-97. DOI: 10.1358/dot.2009.45.3.1343794. View

13.

Kimura A, Kishimoto T . IL-6: regulator of Treg/Th17 balance. Eur J Immunol. 2010; 40(7):1830-5. DOI: 10.1002/eji.201040391. View

14.

Guerrero A, Uchida K, Nakajima H, Watanabe S, Nakamura M, Johnson W . Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice. J Neuroinflammation. 2012; 9:40. PMC: 3310810. DOI: 10.1186/1742-2094-9-40. View

15.

Varin A, Mukhopadhyay S, Herbein G, Gordon S . Alternative activation of macrophages by IL-4 impairs phagocytosis of pathogens but potentiates microbial-induced signalling and cytokine secretion. Blood. 2009; 115(2):353-62. PMC: 2808158. DOI: 10.1182/blood-2009-08-236711. View

16.

Whyte C, Bishop E, Ruckerl D, Gaspar-Pereira S, Barker R, Allen J . Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function. J Leukoc Biol. 2011; 90(5):845-54. DOI: 10.1189/jlb.1110644. View

17.

Angeli V, Faveeuw C, Delerive P, Fontaine J, Barriera Y, Franchimont N . Schistosoma mansoni induces the synthesis of IL-6 in pulmonary microvascular endothelial cells: role of IL-6 in the control of lung eosinophilia during infection. Eur J Immunol. 2001; 31(9):2751-61. DOI: 10.1002/1521-4141(200109)31:9<2751::aid-immu2751>3.0.co;2-4. View

18.

Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei X . IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest. 1998; 101(2):311-20. PMC: 508569. DOI: 10.1172/JCI1368. View

19.

Bogdan C . Nitric oxide and the immune response. Nat Immunol. 2001; 2(10):907-16. DOI: 10.1038/ni1001-907. View

20.

Muzes G, Molnar B, Tulassay Z, Sipos F . Changes of the cytokine profile in inflammatory bowel diseases. World J Gastroenterol. 2012; 18(41):5848-61. PMC: 3491591. DOI: 10.3748/wjg.v18.i41.5848. View